Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Saliva secretion is a physiological process carried out by the major and minor salivary glands. It is regulated primarily by the autonomic nervous system, including cholinergic (muscarinic M1/M3) and adrenergic (alpha1, beta) receptor signaling in acinar and ductal epithelial cells. The process involves the initial secretion of an isotonic fluid by acinar cells, which is later modified by ductal cells to produce hypotonic saliva with electrolyte and protein content tailored to physiological needs. Disruption of this process can occur through diseases (e.g., Sjögren’s syndrome), medications (such as anticholinergics), radiation damage, or systemic conditions, resulting in decreased oral health and quality of life[1][3][5][7][9]. Because "saliva secretion" is not itself a distinct molecule, protein, or receptor, but reflects the action of several molecular targets, its use as a target name is incorrect for the purpose of structured drug target information. Relevant molecular targets involved in saliva secretion would include "Muscarinic acetylcholine receptor M3," "Alpha-1 adrenergic receptor," "Aquaporin-5," and various ion channels and transporters[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Saliva secretion.